Image

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Study on Physical Activity Levels and Overall Survival in Advanced Cancer Patients

Recruiting
18 years and older
All
Phase N/A

This study investigates the relationship between physical activity levels and overall survival in advanced cancer patients. It looks at how physical activity, as measured by devices, is related to health care provider-assessed performance status.

The study evaluates the use of technology to measure physical activity and its potential role in assessing patient performance status. This study investigates gathering evidence on incorporating these measurements into cancer care.

  • Who can participate: Adults aged 18 and older with various types of cancer may participate. Participants must be fluent in English and able to provide informed consent.
  • Study details: Participants will use devices to monitor physical activity and answer questions about their health.
  • Study timelines and visits: The study will last 7 months. The study requires 7 visits.
Study details
    Malignant Head and Neck Neoplasm
    Malignant Neoplasm
    Metastatic Malignant Neoplasm in the Neck
    Metastatic Malignant Neoplasm in the Uterine Cervix
    Pancreatic Adenocarcinoma
    Pancreatic Neuroendocrine Carcinoma
    Recurrent Colorectal Carcinoma
    Stage I Colorectal Cancer AJCC v6 and v7
    Stage I Hypopharyngeal Carcinoma AJCC v7
    Stage I Major Salivary Gland Cancer AJCC v7
    Stage I Nasopharyngeal Carcinoma AJCC v7
    Stage I Oral Cavity Cancer AJCC v6 and v7
    Stage I Oropharyngeal Carcinoma AJCC v6 and v7
    Stage II Colorectal Cancer AJCC v7
    Stage II Hypopharyngeal Carcinoma AJCC v6 and v7
    Stage II Major Salivary Gland Cancer AJCC v7
    Stage II Nasopharyngeal Carcinoma AJCC v7
    Stage II Oral Cavity Cancer AJCC v6 and v7
    Stage II Oropharyngeal Carcinoma AJCC v6 and v7
    Stage IIA Colorectal Cancer AJCC v7
    Stage IIB Colorectal Cancer AJCC v7
    Stage IIC Colorectal Cancer AJCC v7
    Stage III Colorectal Cancer AJCC v7
    Stage III Hypopharyngeal Carcinoma AJCC v7
    Stage III Laryngeal Cancer AJCC v6 and v7
    Stage III Major Salivary Gland Cancer AJCC v7
    Stage III Nasopharyngeal Carcinoma AJCC v7
    Stage III Oral Cavity Cancer AJCC v6 and v7
    Stage III Oropharyngeal Carcinoma AJCC v7
    Stage IIIA Colorectal Cancer AJCC v7
    Stage IIIB Colorectal Cancer AJCC v7
    Stage IIIC Colorectal Cancer AJCC v7
    Stage IV Colorectal Cancer AJCC v7
    Stage IVA Colorectal Cancer AJCC v7
    Stage IVA Hypopharyngeal Carcinoma AJCC v7
    Stage IVA Laryngeal Cancer AJCC v7
    Stage IVA Major Salivary Gland Cancer AJCC v7
    Stage IVA Nasopharyngeal Carcinoma AJCC v7
    Stage IVA Oral Cavity Cancer AJCC v6 and v7
    Stage IVA Oropharyngeal Carcinoma AJCC v7
    Stage IVB Colorectal Cancer AJCC v7
    Stage IVB Hypopharyngeal Carcinoma AJCC v7
    Stage IVB Laryngeal Cancer AJCC v7
    Stage IVB Major Salivary Gland Cancer AJCC v7
    Stage IVB Nasopharyngeal Carcinoma AJCC v7
    Stage IVB Oral Cavity Cancer AJCC v6 and v7
    Stage IVB Oropharyngeal Carcinoma AJCC v7
    Metastatic or Locally Unresectable Solid Tumor

NCT01365169

M.D. Anderson Cancer Center

31 July 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.